Aims To investigate relationships between bone mineral density (BMD), insul
in secretion and insulin sensitivity, controlling for body composition, in
view of data suggesting that hypoglycaemia leads to decreased osteoblast pr
oliferation and a negative calcium balance and that insulin stimulates oste
oblast differentiation and collagen synthesis, with no clear evidence if th
is response in impaired in insulin resistance.
Methods Femur and whole body (WB) BMD was measured in 55 male patients with
ischaemic heart disease and 40 healthy men, using a Hologic QDR-2000 densi
tometer, Insulin sensitivity (S-i) was estimated as the rate of glucose dis
appearance divided by the area under the insulin curve during an intravenou
s glucose tolerance test.
Results Insulin and C-peptide levels were not correlated with BMD, but S-i
was a significant: predictor of femur (log, r = 0.35) and WB BMD (log r = 0
.29, both P < 0.01), even after controlling for weight: and age. Fat mass (
FM) was a predictor of BMD (femur: r = 0.33 P < 0.01, WB: r = 0.43 P < 0.00
1). In the femur the association with FM disappeared when log(S-i) was ente
red in the regression. Lean body mass (LBM) contributed significantly to BM
D (r = 0.50 and r = 0.66, both P < 0.001).
Conclusions These results are compatible with a direct influence of lean bo
dy mass on bone, while the impact of fat mass may consist of insulin resist
ance with increased insulin exposure of bone. It is hypothesized that patie
nts with insulin resistance in the metabolic pathway do not exhibit resista
nce to the skeletal actions of insulin.